Want to join the conversation?
$AMGN reported that the FRAME study also met the secondary endpoint of reducing incidence of clinical fractures in postmenopausal women with osteoporosis through 12 months. However, secondary endpoint of reducing incidence of non-vertebral fractures through months 12 and 24 was not met.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)